Activity
-
First day at ADLM, welcome to visit us at booth 4355. #FLASHDX #SYNDROMICTESTING
First day at ADLM, welcome to visit us at booth 4355. #FLASHDX #SYNDROMICTESTING
Liked by Jesus (Jesse) Alfaro
-
Congrats to Chris Hartman, Adam Hattan, Ibrahim Ali and Bob O'Brien for leading the charge at the SNIS meeting with this critical launch of the…
Congrats to Chris Hartman, Adam Hattan, Ibrahim Ali and Bob O'Brien for leading the charge at the SNIS meeting with this critical launch of the…
Liked by Jesus (Jesse) Alfaro
-
In case you missed it: The NEW #FreeClimb 88 catheter system with #Tenzing 8 delivery catheter is now available! This super-bore access catheter…
In case you missed it: The NEW #FreeClimb 88 catheter system with #Tenzing 8 delivery catheter is now available! This super-bore access catheter…
Liked by Jesus (Jesse) Alfaro
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Languages
-
Spanish
-
More activity by Jesus (Jesse)
-
After 11.5 years at Intuitive in product quality (and 25+ years working in medical device/biotech industry), I am now shifting my focus to being the…
After 11.5 years at Intuitive in product quality (and 25+ years working in medical device/biotech industry), I am now shifting my focus to being the…
Liked by Jesus (Jesse) Alfaro
-
I am approaching the 30 days of being without employment. Technically, it has been a week since the first 20+ days, I was on vacation, overseas…
I am approaching the 30 days of being without employment. Technically, it has been a week since the first 20+ days, I was on vacation, overseas…
Liked by Jesus (Jesse) Alfaro
-
New insights from a sub-analysis of the PRELUDE-BTK study are here! Researchers compared standard balloon angioplasty with the innovative #Serranator…
New insights from a sub-analysis of the PRELUDE-BTK study are here! Researchers compared standard balloon angioplasty with the innovative #Serranator…
Liked by Jesus (Jesse) Alfaro
-
Hoy celebramos el Día del Orgullo en el sitio de Intuitive Mexicali. Los empleados se reunieron para honrar a la comunidad LGBTQ+ y celebrar el Mes…
Hoy celebramos el Día del Orgullo en el sitio de Intuitive Mexicali. Los empleados se reunieron para honrar a la comunidad LGBTQ+ y celebrar el Mes…
Liked by Jesus (Jesse) Alfaro
-
So exciting! Our Cardiac Clamp received Breakthrough Device Designation from the U.S. FDA! We're going after an indication for ablation of cardiac…
So exciting! Our Cardiac Clamp received Breakthrough Device Designation from the U.S. FDA! We're going after an indication for ablation of cardiac…
Liked by Jesus (Jesse) Alfaro
-
2024 marks a Century of Spartans at #SJSU! 🔵🟡💯 Share your favorite memories and stories below to help us build a timeline of the past 100 years.…
2024 marks a Century of Spartans at #SJSU! 🔵🟡💯 Share your favorite memories and stories below to help us build a timeline of the past 100 years.…
Liked by Jesus (Jesse) Alfaro
-
As we mourn the loss of San José State University Judo Coach Yoshihiro “Yosh” Uchida, we also celebrate his incredible life and the profound…
As we mourn the loss of San José State University Judo Coach Yoshihiro “Yosh” Uchida, we also celebrate his incredible life and the profound…
Liked by Jesus (Jesse) Alfaro
-
Connect with us to fulfill your catheter production demand with our top-quality medical tubing! 👉 https://lnkd.in/eAqh-ggp Experience rapid…
Connect with us to fulfill your catheter production demand with our top-quality medical tubing! 👉 https://lnkd.in/eAqh-ggp Experience rapid…
Liked by Jesus (Jesse) Alfaro
-
Dear LinkedIn Community, After an incredible journey at Intuity Medical, I must share some bittersweet news. As many of you may know, Intuity…
Dear LinkedIn Community, After an incredible journey at Intuity Medical, I must share some bittersweet news. As many of you may know, Intuity…
Liked by Jesus (Jesse) Alfaro
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More